COST-EFFECTIVENESS OF COMPLYING WITH TREATMENT GUIDELINES IN SWEDEN

被引：0
|
作者：
Jonsson, E. [1 ]
Hansson-Hedblom, A. [1 ]
Ljunggren, O. [2 ]
Akesson, K. [3 ]
Spangeus, A. [4 ]
Borgstrom, F. [1 ,5 ]
Kanis, J. A. [6 ,7 ]
机构：
[1] Quantify Res, Stockholm, Sweden
[2] Uppsala Univ, Dept Med Sci Endocrinol & Mineral Metab, Uppsala, Sweden
[3] Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Unit, Malmo, Sweden
[4] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden
[5] Karolinska Inst, Stockholm, Sweden
[6] Catholic Univ Australian, Melbourne, Vic, Australia
[7] Univ Sheffield, Sheffield, S Yorkshire, England
来源：
OSTEOPOROSIS INTERNATIONAL | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P747
引用
收藏
页码：S440 / S440
页数：1
相关论文
共 50 条
  • [1] THE COST-EFFECTIVENESS OF HYPERTENSION TREATMENT IN SWEDEN
    JOHANNESSON, M
    PHARMACOECONOMICS, 1995, 7 (03) : 242 - 250
  • [2] Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
    Knight, Christopher
    Mauskopf, Josephine
    Ekelund, Mats
    Singh, Amitabh
    Yang, Shiyi
    Boggs, Robert
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (02): : 145 - 156
  • [3] Cost-effectiveness of treatment with etanercept for psoriasis in Sweden
    Christopher Knight
    Josephine Mauskopf
    Mats Ekelund
    Amitabh Singh
    Shiyi Yang
    Robert Boggs
    The European Journal of Health Economics, 2012, 13 : 145 - 156
  • [4] COST-EFFECTIVENESS OF EXTENDED ADJUVANT TREATMENT WITH LETROZOLE IN SWEDEN
    Lundkvist, J.
    Lindman, H.
    VALUE IN HEALTH, 2008, 11 (06) : A471 - A471
  • [5] Cost-effectiveness of alendronate for the treatment of male osteoprosis in Sweden
    Borgström, F
    Sen, SS
    Johnell, O
    Jönsson, B
    Jönsson, L
    Zethreaus, N
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S45 - S45
  • [6] Treatment guidelines - cost-effectiveness analysis and finding the comparator
    不详
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2024, 29 (03): : 142 - 142
  • [7] The cost-effectiveness of early cabergoline treatment compared to levodopa in Sweden
    P. Lindgren
    B. Jönsson
    J. DuChane
    The European Journal of Health Economics, 2003, 4 (1) : 37 - 42
  • [8] Cost-effectiveness of infliximab (Remicade) in Sweden
    Kobelt, G
    Jonsson, L
    Lindquist, E
    Eberhardt, K
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S158 - S158
  • [9] The cost-effectiveness of inhaled insulin in Sweden
    Neovius, M.
    Pruz, C.
    VALUE IN HEALTH, 2006, 9 (06) : A231 - A231
  • [10] THE COST-EFFECTIVENESS OF ROFLUMILAST FOR COPD IN SWEDEN
    Engstrom, A.
    VALUE IN HEALTH, 2011, 14 (07) : A494 - A494
12345